Antimicrobial Sensitivity and Resistance Trends in Bacterial Respiratory Isolates from Adults with Lower Respiratory Tract Infections
DOI:
https://doi.org/10.51985/Keywords:
Acinetobacter baumannii; Antimicrobial resistance; Antimicrobial stewardship; Colistin resistance; Lower respiratory tract infections; Methicillin-resistant Staphylococcus aureus; PakistanAbstract
Objective: To characterize the bacteriological profile and antimicrobial resistance patterns of respiratory isolates from adults with LRTIs at a tertiary care hospital in Karachi, Pakistan.
Methods: A retrospective observational study was conducted at Combined Military Hospital (CMH) Malir, Karachi, from October 2024 to March 2025. Of 112 symptomatic hospitalized adults evaluated, 67 provided adequate respiratory specimens. Of these, 24 (36%) were Tuberculosis (TB) positive and were excluded from bacterial culture analysis. The remaining 43 (64%) underwent bacterial culture. Isolates were identified using standard biochemical methods. Antimicrobial susceptibility testing followed CLSI guidelines (M100, 36th edition; M07, 12th edition), with broth microdilution exclusively for colistin. SPSS version 25 was used for statistical analysis.
Results: Gram-negative bacteria accounted for 88% of isolates. Acinetobacter baumannii (35%), Klebsiella pneumoniae (21%), and Pseudomonas aeruginosa (14%) predominated. All Gram-positive isolates were methicillin-resistant Staphylococcus aureus (MRSA, 11%), susceptible to linezolid and vancomycin. A. baumannii showed 80% carbapenem resistance; K. pneumoniae showed 77% resistance to fluoroquinolones and co-trimoxazole, while 67% P. aeruginosa isolates were carbapenem-resistant. Prior antibiotic use (49%), smoking (46%), and COPD (19%) were common risk factors.
Conclusion: High resistance among respiratory Gram-negative pathogens underscores the need for antimicrobial stewardship, culture-guided prescribing, and continuous local surveillance.
Downloads
References
1. GBD 2023 Lower Respiratory Infections and Antimicrobial
Resistance Collaborators. Global burden of lower respiratory
infections and aetiologies, 1990–2023: a systematic analysis
for the Global Burden of Disease Study 2023. Lancet Infect
Dis. 2026;26(4):343–361. doi:10.1016/S1473-3099(25)00689-
9
2. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles
Aguilar G, Gray A, et al. Global burden of bacterial
antimicrobial resistance in 2019: a systematic analysis. Lancet.
2022;399(10325):629–655. doi:10.1016/S0140-6736(21)
02724-0
3. GBD 2021 Antimicrobial Resistance Collaborators. Global
burden of bacterial antimicrobial resistance 1990–2021: a
systematic analysis with forecasts to 2050. Lancet.
2024;404(10459):1199–1226. doi:10.1016/S0140-6736(24)
01867-1
4. Ikuta KS, Swetschinski LR, Aguilar GR, Sharara F, Mestrovic
T, Gray A, et al. The WHO Bacterial Priority Pathogens List
2024: a prioritisation study to guide research, development,
and public health strategies against antimicrobial resistance.
Lancet Infect Dis. 2025;25(5):588–600. doi:10.1016/S1473-
3099(25)00118-5
5. Sarwar M, Siddiqi FA, Riaz S, Chaudhry AH, Hassan M,
Hussain A. Multidrug-resistant organisms and their association
with risk factors: a study at the intensive care unit of a tertiary
care hospital, Peshawar. Pak Armed Forces Med J. 2023;73(6):
1769–1772. doi:10.51253/pafmj.v73i6.10323
6. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic
resistance in Pseudomonas aeruginosa: mechanisms and
alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):
177–192. doi:10.1016/j.biotechadv.2018.11.012
7. Ijaz M, Khan M, Yasin H. Evaluation and molecular
characterization of colistin-resistant isolates of Pseudomonas
aeruginosa and Klebsiella pneumoniae from infected wounds
of hospitalized patients. J Microbiol Biotechnol. 2024;34(10):
2087–2095. doi:10.4014/jmb.2407.07005
8. Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler
VG Jr. Staphylococcus aureus infections: epidemiology,
pathophysiology, clinical manifestations, and management.
Clin Microbiol Rev. 2015;28(3):603–661. doi:10.1128/CMR.
00134-14
9. Chen G, Xu K, Sun F, Sun Y, Kong Z, Fang B, et al. Risk
factors of multidrug-resistant bacteria in lower respiratory
tract infections: a systematic review and meta-analysis. Biomed
Res Int. 2020;2020:7268519. doi:10.1155/2020/7268519
10. Iqbal J, Khan W, Khurshid M, Ahmed H, Khan MT, Siddique
AB, et al. Evaluating the burden of respiratory tract infections
among mortality cases in Karachi, Pakistan: a post-pandemic
surveillance analysis. J Glob Health. 2025;15:04198. doi:10.
7189/jogh.15.04198
11. Clinical and Laboratory Standards Institute. Performance
standards for antimicrobial susceptibility testing. CLSI
supplement M100. 36th ed. Wayne (PA): CLSI; 2026.
12. Clinical and Laboratory Standards Institute. Methods for
dilution antimicrobial susceptibility tests for bacteria that
grow aerobically. CLSI standard M07. 12th ed. Wayne (PA):
CLSI; 2024.
13. Karampatakis T, Tsergouli K, Behzadi P. Pan-genome plasticity
and virulence factors: a closer snapshot at Klebsiella
pneumoniae. Antibiotics (Basel). 2023;12(2):243. doi:10.3390/
antibiotics12020243
14. Jabeen F, Khan Z, Sohail M, Akhter N, Jabeen K, Farooqi
BJ, et al. Antibiotic resistance pattern of Acinetobacter
baumannii isolated from bacteraemia patients in Pakistan. J
Ayub Med Coll Abbottabad. 2022;34(1):95–100. doi:10.55519/
JAMC-01-9105
15. Gondal AJ, Choudhry N, Bukhari H, Rizvi Z, Jahan S, Yasmin
N. Estimation, evaluation and characterisation of carbapenem
resistance burden from a tertiary care hospital, Pakistan.
Antibiotics (Basel). 2023;12(3):525. doi:10.3390/antibiotics
12030525
16. Azara M, Almeida CF, Santos RCV, Rodrigues MV, Ferreira
DC, Matias JCO, et al. Epidemiology of multidrug-resistant
Klebsiella pneumoniae in clinical settings in South-Eastern
Asia: a systematic review and meta-analysis. Antimicrob
Resist Infect Control. 2023;12(1):148. doi:10.1186/s13756-
023-01346-5
17. Irshad M, Sethi SM, Jamil B, Zafar A, Hasan R, Farooqi J,
et al. Impact of an antimicrobial stewardship program on
colistin resistance in a tertiary care hospital in Pakistan: a
quasi-experimental study. GMS Infect Dis. 2025;13:Doc07.
doi:10.3205/id000097
18. Wang Y, Zhang L, Chen Y, Hu Z, Wu Y, Zhang H, et al.
Efficacy and safety of antibiotics in the treatment of methicillinresistant Staphylococcus aureus infections: a systematic review
and network meta-analysis. Antibiotics (Basel). 2024;13(9):
866. doi:10.3390/antibiotics13090866
19. Khan L, Naz F, Zeb M, Rehman SU. Antibiotic stewardship
in hospital-acquired pneumonia. Cureus. 2024;16(11):e73623.
doi:10.7759/cureus.73623
20. Shah N, Ahmad I, Khan M, Iqbal R, Khan S, Ullah A, et al.
Prevalence and antimicrobial susceptibility of Acinetobacter
spp. in a tertiary care hospital in Peshawar: a cross-sectional
study. PLOS Glob Public Health. 2023;3(5):e0001899. doi:10.
1371/journal.pgph.0001899
21. Altaf U, Saleem Z, Akhtar MF, Naseem W, Javaid Z, Waqar
M, et al. Using culture sensitivity reports to optimise
antimicrobial therapy: findings and implications of
antimicrobial stewardship activity in a hospital in Pakistan.
Medicina (Kaunas). 2023;59(7):1237. doi:10.3390/medicina
59071237
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0
